Intravenous immunoglobulin (IVIG) therapy acts independently of the neonatal Fc-receptor in experimental epidermolysis bullosa acquisita

被引：0
|
作者：
Kasperkiewicz, M. [1 ]
Ishii, N. [1 ]
Hirose, M. [1 ]
Freitag, M. [1 ]
Schmidt, E. [1 ]
Recke, A. [1 ]
Zillikens, D. [1 ]
Ludwig, R. J. [1 ]
机构：
[1] Med Univ Lubeck, Klin Dermatol Allergol & Venerol, D-23538 Lubeck, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2009年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 44 条
  • [1] Intravenous Immunoglobulin Therapy is Effective and Acts Independently of the Neonatal Fc-receptor in Experimental Epidermolysis Bullosa Acquisita
    Kasperkiewicz, M.
    Ishii, N.
    Hirose, M.
    Freitag, M.
    Schmidt, E.
    Recke, A.
    Zillikens, D.
    Ludwig, R. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S95 - S95
  • [2] Successful and from neonatal fc-receptor non-dependent effect of high dose intravenous immunglobulin (IVIG) in experimental epidermolysis bullosa acquisita (EBA)
    Kasperkiewicz, M.
    Ishii, N.
    Hirose, M.
    Recke, A.
    Zillikens, D.
    Ludwig, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 156 - 157
  • [3] Successful treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin (IVIg)
    Kalavala, M
    Motley, R
    Khan, S
    Subedi, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB137 - AB137
  • [4] Intravenous immunciglobulin (IVIG) is effective in experimental epidermolysis bullosa acquisita
    Ludwig, R. I.
    Ishii, N.
    Kasperkiewicz, M.
    Chiriac, M.
    Zillikens, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S24 - S24
  • [5] The neonatal Fc receptor promotes tissue injury in experimental epidermolysis bullosa acquisita
    Sesarman, A.
    Sitaru, A. G.
    Olaru, F.
    Zillikens, D.
    Sitaru, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S31 - S31
  • [6] Results of intravenous immunoglobulin therapy in ocular involvement in epidermolysis bullosa acquisita
    Sami, N
    Ahmed, AR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U329 - U329
  • [7] Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita
    Kofler, H
    WambacherGasser, B
    Topar, G
    Weinlich, G
    Schuler, C
    Hintner, H
    Romani, N
    Fritsch, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : 331 - 335
  • [8] Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita
    Alina Sesarman
    Ana Gabriela Sitaru
    Florina Olaru
    Detlef Zillikens
    Cassian Sitaru
    Journal of Molecular Medicine, 2008, 86 : 951 - 959
  • [9] Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita
    Sesarman, Alina
    Sitaru, Ana Gabriela
    Olaru, Florina
    Zillikens, Detlef
    Sitaru, Cassian
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (08): : 951 - 959
  • [10] Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
    Kasprick, Anika
    Hofrichter, Maxi
    Smith, Bryan
    Ward, Penelope
    Bieber, Katja
    Shock, Anthony
    Ludwig, Ralf J.
    Schmidt, Enno
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (10) : 2381 - 2392
12345